Share Share Share

MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab

ONCOTARGET

Mlcochova, J; Faltejskova-Vychytilova, P; Ferracin, M; Zagatti, B; Radova, L; Svoboda, M; Nemecek, R; John, S; Kiss, I; Vyzula, R; Negrini, M; Slaby, O, 2015: MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab. ONCOTARGET 6(36), p. 38695 - 38704

Research Groups:

• Molecular Oncology - Solid Cancer

CEITEC authors:

• Jitka Vaňáčková, Ph.D.
• Petra Vychytilová, Ph.D.
• Lenka Radová, Ph.D.
• Prof. Ondřej Slabý, Ph.D.